Sunshine Biopharma Inc. Inventory
Sunshine Biopharma Inc. (SBFM) had Inventory of $12.12 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2026-08-13
- 2026-06-30: Inventory, Net $12.12M.
- 2026-03-31: Inventory, Net $13.17M.
- 2025-12-31: Inventory, Net $13.47M.
- 2025-09-30: Inventory, Net $14.06M.
| Period end | Inventory, Net |
|---|---|
| 2026-06-30 | $12.12M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $13.17M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $13.47M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $14.06M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $13.02M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $11.86M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $11.28M 10-K · filed 2026-04-03 |
| 2024-09-30 | $9.82M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $8.49M 10-Q/A · filed 2024-08-20 |
| 2024-03-31 | $7.70M 10-Q · filed 2024-05-20 |
| 2023-12-31 | $5.73M 10-K · filed 2025-04-01 |
| 2023-09-30 | $4.52M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $4.25M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $3.71M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $3.29M 10-K · filed 2024-03-28 |
| 2022-09-30 | $269.64K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $205.37K 10-Q · filed 2022-08-03 |
| 2022-03-31 | $181.50K 10-Q · filed 2022-05-06 |
| 2021-12-31 | $105.65K 10-K · filed 2023-04-04 |
| 2021-09-30 | $71.31K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $45.22K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $26.66K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $23.77K 10-K · filed 2022-03-21 |
| 2020-09-30 | $26.20K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $16.58K 10-Q/A · filed 2020-08-31 |
| 2020-03-31 | $13.71K 10-Q · filed 2020-05-18 |
| 2019-12-31 | $15.91K 10-Q · filed 2020-11-12 |
| 2019-09-30 | $17.78K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $18.19K 10-Q · filed 2019-08-15 |
| 2019-03-31 | $13.24K 10-Q · filed 2019-05-20 |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |